Wednesday, December 21, 2016

BRIEF-Advanced Accelerator Applications receives complete response letter from FDA for Lutathera

* Advanced Accelerator Applications receives complete

response letter from FDA for Lutathera, an investigational

treatment for neuroendocrine tumors

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)